OTCMKTS:ISCO - International Stem Cell Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$1.65 -0.01 (-0.60 %)
(As of 06/22/2018 04:00 PM ET)
Previous Close$1.66
Today's Range$1.65 - $1.69
52-Week Range$1.07 - $2.05
Volume5,980 shs
Average Volume7,129 shs
Market Capitalization$10.53 million
P/E Ratio-1.13
Dividend YieldN/A
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on development of therapeutic and biomedical products worldwide. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cells. It develops cell types, including neural stem cells for the treatment of Parkinson's disease and other neurological disorders; liver cells to treat various congenital and acquired liver diseases; islet cells for treatment of diabetes; and retinal cells and three-dimensional eye structures to treat degenerative retinal diseases and corneal blindness, as well as to accelerate corneal healing. The company also develops, manufactures, and markets skincare products and human cell culture products. Its human cell culture products include human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cells from the heart and blood vessels, and reagents to study cardiovascular disease and cancer; human bronchial and tracheal cell lines for the study of toxicity, cystic fibrosis, asthma, and pathogenesis; and human mammary epithelial cell lines for the study of breast cancer, three dimensional culture, and carcinogen screening. The company's human cell culture products also comprise adult stem cells and reagents for regenerative medicine; human prostate cells and specialized medium to study prostate disease; human renal and bladder cells and media to study renal and bladder diseases; human corneal cells and media for the study of corneal disease; and other cell culture reagents and supplements for the growth, staining, and freezing of human cells. It sells skincare products through a branded Website, professional channels, and distributors; and human cell culture products through its sales force, OEM partners, and brand distributors. International Stem Cell Corporation was founded in 2001 and is headquartered in Carlsbad, California.

Receive ISCO News and Ratings via Email

Sign-up to receive the latest news and ratings for ISCO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations


Debt-to-Equity RatioN/A
Current Ratio0.59
Quick Ratio0.35


Trailing P/E Ratio-1.13
Forward P/E Ratio-1.68
P/E GrowthN/A

Sales & Book Value

Annual Sales$7.46 million
Price / Sales1.37
Cash FlowN/A
Price / CashN/A
Book Value$0.34 per share
Price / Book4.85


EPS (Most Recent Fiscal Year)($1.46)
Net Income$-6,060,000.00
Net Margins-47.19%
Return on Equity-300.39%
Return on Assets-51.07%


Outstanding Shares6,200,000

International Stem Cell (OTCMKTS:ISCO) Frequently Asked Questions

What is International Stem Cell's stock symbol?

International Stem Cell trades on the OTCMKTS under the ticker symbol "ISCO."

How were International Stem Cell's earnings last quarter?

International Stem Cell Corp (OTCMKTS:ISCO) released its quarterly earnings results on Tuesday, May, 22nd. The biotechnology company reported ($0.14) EPS for the quarter. The biotechnology company had revenue of $2.63 million for the quarter. International Stem Cell had a negative return on equity of 300.39% and a negative net margin of 47.19%. View International Stem Cell's Earnings History.

When is International Stem Cell's next earnings date?

International Stem Cell is scheduled to release their next quarterly earnings announcement on Monday, August, 13th 2018. View Earnings Estimates for International Stem Cell.

Who are some of International Stem Cell's key competitors?

Who are International Stem Cell's key executives?

International Stem Cell's management team includes the folowing people:
  • Prof. Andrey Semechkin Ph.D., Co-Chairman & Chief Exec. Officer (Age 58)
  • Dr. Russell Kern Ph.D., Exec. VP, Chief Scientific Officer & Inside Director (Age 32)
  • Mr. Charles J. Casamento MBA, Exec. Director (Age 73)
  • Mr. Kenneth C. Aldrich J.D., Co-Founder and Chairman Emeritus (Age 79)
  • Ms. Sophia Garnette J.D., VP of Legal Affairs & Operations (Age 34)

Has International Stem Cell been receiving favorable news coverage?

Media stories about ISCO stock have been trending somewhat positive this week, according to Accern. The research firm rates the sentiment of press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. International Stem Cell earned a media sentiment score of 0.11 on Accern's scale. They also assigned media stories about the biotechnology company an impact score of 48.19 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next several days.

How do I buy shares of International Stem Cell?

Shares of ISCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is International Stem Cell's stock price today?

One share of ISCO stock can currently be purchased for approximately $1.65.

How big of a company is International Stem Cell?

International Stem Cell has a market capitalization of $10.53 million and generates $7.46 million in revenue each year. The biotechnology company earns $-6,060,000.00 in net income (profit) each year or ($1.46) on an earnings per share basis. International Stem Cell employs 40 workers across the globe.

How can I contact International Stem Cell?

International Stem Cell's mailing address is 5950 PRIESTLY DRIVE, CARLSBAD CA, 92008. The biotechnology company can be reached via phone at 760-940-6383 or via email at [email protected]

MarketBeat Community Rating for International Stem Cell (ISCO)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  48 (Vote Outperform)
Underperform Votes:  58 (Vote Underperform)
Total Votes:  106
MarketBeat's community ratings are surveys of what our community members think about International Stem Cell and other stocks. Vote "Outperform" if you believe ISCO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ISCO will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.